A development stage company located in Halifax Nova Scotia Chelation Partners technology constitutes a new platform of chemically synthesized chelating compounds that withhold iron from pathogens. The new compounds inhibit growth of microbes and greatly enhance the activities of antibiotics against bacterial and fungal pathogens. (BIOTECanada)